Bio Green Med Solution (BGMS) EBIT (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly EBIT of -$246000.0 for Q1 2026, up 94.16% year-over-year from -$126698.1 in Q1 2025, and up 77.26% quarter-over-quarter from -$1.1 million in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) EBIT (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported EBIT for 17 consecutive years, with -$246000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT rose 94.16% year-over-year to -$246000.0; the TTM figure through Mar 2026 stood at -$3.6 million (up 69.34% YoY), while the FY2025 annual figure was -$8.4 million, up 29.8% from the prior year.
- EBIT improved to -$246000.0 in Q1 2026 per BGMS's latest filing, from -$1.1 million in the prior quarter.
- Across five years, EBIT topped out at -$246000.0 in Q1 2026 and bottomed at -$8.8 million in Q4 2022.
- Historically, EBIT has averaged -$4.3 million across 5 years, with a median of -$4.4 million in 2024.
- Annual changes were most pronounced in 2022 — EBIT sank 52.36% — and 2026, when it surged 94.16%.
- Bio Green Med Solution's EBIT stood at -$8.8 million in 2022, then soared by 39.4% to -$5.4 million in 2023, then surged by 65.9% to -$1.8 million in 2024, then surged by 40.81% to -$1.1 million in 2025, then surged by 77.26% to -$246000.0 in 2026.
- Business Quant data shows BGMS's EBIT at -$246000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$992000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -815.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | -505.13 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 325.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | -418,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -418,000.00 |
| Mar 31, 2026 | -246,000.00 |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -992,000.00 |
| Jun 30, 2025 | -1.25 Mn |
| Mar 31, 2025 | -4.21 Mn |
| Dec 31, 2024 | -1.83 Mn |
| Sep 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -3.64 Mn |
| Mar 31, 2024 | -4.36 Mn |
| Dec 31, 2023 | -5.36 Mn |
| Sep 30, 2023 | -6.85 Mn |
| Jun 30, 2023 | -5.93 Mn |
| Mar 31, 2023 | -7.32 Mn |
| Dec 31, 2022 | -8.85 Mn |
| Sep 30, 2022 | -6.47 Mn |
| Jun 30, 2022 | -5.79 Mn |
| Mar 31, 2022 | -6.56 Mn |
| Dec 31, 2021 | -6.28 Mn |
| Sep 30, 2021 | -5.70 Mn |